2001-2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa

A/RES/63/234View PDF

Who adopted this document and its mandates?

A Resolution of the General Assembly, under agenda item 43 2001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in Africa, published in 2009.

What other versions does this mandate have?

2 versions · 2001–2009

Year	Symbol	Title	Word length	Text similarity
2009	A/RES/63/234	2001-2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa	2,938	14%Compare
2001	A/RES/55/284	2001-2010 :#Decade to Roll Back Malaria in Developing Countries, Particularly in Africa	862	–

What’s in this document?

38 operative paragraphs

Welcomes the report prepared by the World Health Organization,⁸ and calls for support for the recommendations contained therein;

⁸See A/63/219.

Also welcomes the Global Malaria Action Plan, which provides for the first time a comprehensive plan for combating malaria in the short, medium and long term, including by giving further impetus to internationally agreed targets of universal coverage of malaria interventions for all at-risk populations by 2010, of continuing the scale-up to achieve nearly zero preventable deaths from malaria by 2015 and of eliminating and, with additional research and development, ultimately eradicating the disease;

Further welcomes the theme “Malaria - a disease without borders” that was chosen for the first World Malaria Day, as well as activities undertaken by the Member States, relevant organizations of the United Nations system, international institutions, non-governmental organizations, the private sector and civil society to commemorate this day, and encourages them to continue to observe World Malaria Day and to collaborate in the observance of the final two years of the Decade to Roll Back Malaria in Developing Countries, Particularly in Africa, in order to raise public awareness of and knowledge about the prevention, control and treatment of malaria as well as the importance of meeting the Millennium Development Goals;

Welcomes the designation by the Secretary-General of a Special Envoy for Malaria to raise the issue in collaboration with other United Nations organizations already working on those issues on the international political and development agendas and to work with national and global leaders to help to secure the political will, the partnerships and the funds to drastically reduce malaria deaths by 2010 through increased access to protection and treatment, especially in Africa;

Also welcomes the adoption by the sixty-first World Health Assembly of resolution 61.21 of 24 May 2008,⁹ in which it adopted the global strategy and the agreed parts of the plan of action on public health, innovation and intellectual property;

⁹See World Health Organization, Sixty-first World Health Assembly, Geneva, 19–24 May 2008, Resolutions and Decisions, Annexes (WHA61/2008/REC/1).

Further welcomes the increased funding for malaria interventions and for research and development of preventive and control tools from the international community, through funding from multilateral and bilateral sources and from the private sector, as well as by making predictable financing available through appropriate and effective aid modalities and in-country health financing mechanisms aligned with national priorities, which are key to strengthening health systems and promoting universal and equitable access to high-quality malaria prevention and treatment services;

Welcomes recent commitments and initiatives to promote overall malaria prevention, control and treatment, including those announced at the high-level event on the Millennium Development Goals, held in New York on 25 September 2008;

Also welcomes World Health Assembly resolution 61.18 of 24 May 2008,8 in which the Assembly initiated annual monitoring of the achievement of the health-related Millennium Development Goals;

Urges the international community to deliver on programmes and activities at the country level in order to achieve internationally agreed targets on malaria;

Calls upon the international community to continue to support the secretariat of the Roll Back Malaria Partnership and partner organizations, including the World Health Organization, the World Bank and the United Nations Children’s Fund, as vital complementary sources of support for the efforts of malaria-endemic countries to combat the disease;

Appeals to the international community to work in a spirit of cooperation towards effective, increased, harmonized and sustained bilateral and multilateral assistance to combat malaria, including support for the Global Fund to Fight AIDS, Tuberculosis and Malaria, in order to assist States, in particular malaria-endemic countries, to implement sound national plans, in particular health plans and sanitation plans, including malaria control strategies and integrated management of childhood illnesses, in a sustained and equitable way that, inter alia, contributes to health system development;

Appeals to the malaria partners to resolve the financial and delivery bottlenecks that are responsible for stock-outs of long-lasting insecticide-treated nets, artemisinin-based combination therapies and rapid diagnostic tests at the national level, whenever they occur, including through the strengthening of malaria programme management at the country level;

Welcomes the contribution to the mobilization of additional and predictable resources for development by voluntary innovative financing initiatives taken by groups of Member States, and in this regard notes the International Drug Purchase Facility, UNITAID, the International Finance Facility for Immunization, the Affordable Medicines Facility for Malaria, the Global Alliance for Vaccines and Immunization and the advance market commitment initiatives;

Urges malaria-endemic countries to work towards financial sustainability, to increase, to the extent possible, domestic resource allocation to malaria control and to create favourable conditions for working with the private sector in order to improve access to good-quality malaria services;

Urges Member States to assess and respond to the needs for integrated human resources at all levels of the health system, in order to achieve the targets of the Abuja Declaration on Roll Back Malaria in Africa¹⁰ and the internationally agreed development goals of the United Nations Millennium Declaration,2 to take actions, as appropriate, to effectively govern the recruitment, training and retention of skilled health personnel, and to give particular focus to the availability of skilled personnel at all levels to meet technical and operational needs as increased funding for malaria control programmes becomes available;

¹⁰A/55/240/Add.1, annex.

Calls upon the international community, inter alia, by helping to meet the financial needs of the Global Fund to Fight AIDS, Tuberculosis and Malaria and through country-led initiatives with adequate international support, to intensify access to affordable, safe and effective antimalarial combination treatments, intermittent preventive treatment in pregnancies, long-lasting insecticide-treated mosquito nets, including, where appropriate, through the free distribution of such nets and, where appropriate, to insecticides for indoor residual spraying for malaria control, taking into account relevant international rules, including the Stockholm Convention on Persistent Organic Pollutants¹¹ standards and guidelines;

¹¹United Nations, Treaty Series, vol. 2256, No. 40214.

Requests relevant international organizations, in particular the World Health Organization and the United Nations Children’s Fund, to assist efforts of national Governments to provide universal access to malaria control interventions to at-risk young children and pregnant women in malaria-endemic countries, particularly in Africa, as rapidly as possible, with due regard to ensuring proper use of those interventions, including long-lasting insecticide nets, and sustainability through full community participation and implementation through the health system;

Calls upon Member States, in particular malaria-endemic countries, to establish and/or strengthen national policies and operational plans, with a view to ensuring the achievement of the targets for 2010 and 2015, in accordance with the technical recommendations of the World Health Organization, so as to ensure the achievement of targets set out in the Global Malaria Action Plan and to promote the achievement of the malaria-related Millennium Development Goals;

Encourages all African countries that have not yet done so to implement the recommendations of the Abuja Summit in 20004 to reduce or waive taxes and tariffs for nets and other products needed for malaria control, both to reduce the price of the products to consumers and to stimulate free trade in those products;

Invites all malaria-endemic countries, with the support of the international community, to scale up their efforts to meet the internationally agreed targets on malaria for 2010 and 2015;

Calls upon United Nations agencies and their partners to continue to provide the technical support necessary to build and enhance the planning and implementation capacity of Member States to meet the internationally agreed goals;

Expresses its concern about the increase in resistant strains of malaria in several regions of the world, and calls upon Member States, with support from the World Health Organization and other partners, to strengthen surveillance systems for drug and insecticide resistance and upon the World Health Organization to coordinate a global network for the monitoring of drug and insecticide resistance and to ensure that drug and insecticide testing is fully operational in order to enhance the use of current insecticide- and artemisinin-based combination therapies;

Urges all Member States experiencing resistance to conventional monotherapies to replace them with combination therapies, as recommended by the World Health Organization, and to develop the necessary financial, legislative and regulatory mechanisms in order to introduce artemisinin combination therapies at affordable prices and to prohibit the marketing of oral artemisinin monotherapies, in a timely manner;

Recognizes the importance of the development of safe and cost-effective vaccines and new medicines to prevent and treat malaria and the need for further and accelerated research, including into safe, effective and high-quality traditional therapies, using rigorous standards, including by providing support to the Special Programme for Research and Training in Tropical Diseases¹² and through effective global partnerships, such as the various malaria vaccine initiatives and the Medicines for Malaria Venture, where necessary stimulated by new incentives to secure their development and through effective and timely support towards pre-qualification of new antimalarials and their combinations;

¹²A joint programme of the United Nations Children’s Fund, the United Nations Development Programme, the World Bank and the World Health Organization.

Calls upon the international community, including through existing partnerships, to increase investment in and efforts towards the research and development of new, safe and affordable malaria-related medicines, products and technologies, such as vaccines, rapid diagnostic tests, insecticides and delivery modes, to prevent and treat malaria, especially for at-risk children and pregnant women, in order to enhance effectiveness and delay the onset of resistance;

Calls upon malaria-endemic countries to assure favourable conditions for research institutions, including allocation of adequate resources and development of national policies and legal frameworks, where appropriate, with a view to, inter alia, informing policy formulation and strategic interventions on malaria;

Reaffirms the right to use, to the fullest extent, the provisions contained in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement),¹³ the Doha Declaration on the TRIPS Agreement and Public Health,¹⁴ the decision of the World Trade Organization’s General Council of 30 August 2003¹⁵ and amendments to article 31 of the Agreement,¹⁶ which provide flexibilities for the protection of public health, and in particular to promote access to medicines for all, including the production, under compulsory licensing, of generic drugs in the prevention and treatment of malaria, and resolves to assist developing countries in this regard;

¹³See Legal Instruments Embodying the Results of the Uruguay Round of Multilateral Trade Negotiations, done at Marrakesh on 15 April 1994 (GATT secretariat publication, Sales No. GATT/1994–7).

¹⁴World Trade Organization, document WT/MIN(01)/DEC/2. Available from http://docsonline.wto.org.

¹⁵See World Trade Organization, document WT/L/540 and Corr.1. Available from http://docsonline.wto.org.

¹⁶See World Trade Organization, document WT/L/641. Available from http://docsonline.wto.org.

Calls upon the international community to support ways to expand access to and the affordability of key products, such as vector control measures, including indoor residual spraying, long-lasting insecticide-treated nets and artemisinin-based combination therapy for populations at risk of exposure to resistant strains of falciparum malaria in malaria-endemic countries, particularly in Africa, including through additional funds and innovative mechanisms, inter alia, for the financing and scaling up of artemisinin production and procurement, as appropriate, to meet the increased need;

Welcomes the increased level of public-private partnerships for malaria control and prevention, including the financial and in-kind contributions of private sector partners and companies operating in Africa, as well as the increased engagement of non-governmental service providers;

Encourages the producers of long-lasting insecticide-treated nets to accelerate technology transfer to developing countries, and the World Bank and regional development funds to consider supporting malaria-endemic countries in establishing factories to scale up production of long-lasting insecticide-treated nets;

Calls upon the international community and malaria-endemic countries, in accordance with existing guidelines and recommendations of the World Health Organization and the requirements of the Stockholm Convention to increase capacity for the safe, effective and judicious use of indoor residual spraying and other forms of vector control;

Urges the international community to become fully knowledgeable about World Health Organization technical policies and strategies and the provisions in the Stockholm Convention related to the use of DDT, including for indoor residual spraying, long-lasting insecticide-treated nets and case management, intermittent preventive treatment for pregnant women and monitoring of in vivo resistance studies to artemisinin-based combination therapy treatment, so that projects support those policies, strategies and provisions;

Requests the World Health Organization, the United Nations Children’s Fund and donor agencies to provide support to those countries which choose to use DDT for indoor residual spraying so as to ensure that it is implemented in accordance with international rules, standards and guidelines, and to provide all possible support to malaria-endemic countries to manage the intervention effectively and prevent the contamination, in particular, of agricultural products with DDT and other insecticides used for indoor residual spraying;

Encourages the World Health Organization and its member States, with the support of the parties to the Stockholm Convention, to continue to explore possible alternatives to DDT as a vector control agent;

Calls upon malaria-endemic countries to encourage regional and intersectoral collaboration, both public and private, at all levels, especially in education, health, agriculture, economic development and the environment, to advance malaria control objectives;

Calls upon the international community to support increased interventions, in line with the Global Malaria Action Plan and the recommendations of the World Health Organization and the Roll Back Malaria Partnership, in order to ensure their rapid, efficient and effective implementation, to strengthen health systems and national pharmaceutical policies, to monitor and fight against the trade in counterfeit antimalarial medicines and prevent the distribution and use of them, and to support coordinated efforts, inter alia, by providing technical assistance to improve surveillance, monitoring and evaluation systems and their alignment with national plans and systems so as to better track and report changes in coverage, the need for scaling up recommended interventions and the subsequent reductions in the burden of malaria;

Urges Member States, the international community and all relevant actors, including the private sector, to promote the coordinated implementation and enhance the quality of malaria-related activities, including via the Roll Back Malaria Partnership, in accordance with national policies and operational plans that are consistent with the technical recommendations of the World Health Organization and recent efforts and initiatives, including, where appropriate, the Paris Declaration on Aid Effectiveness and the Accra Agenda for Action, adopted during the Third High-level Forum on Aid Effectiveness, held in Accra from 2 to 4 September 2008;¹⁷

¹⁷A/63/539, annex.

Requests the Secretary-General, in close collaboration with the Director-General of the World Health Organization and in consultation with Member States, to submit to the General Assembly at its sixty-fourth session an evaluation report on progress achieved towards the internationally agreed targets for 2010, including funding and implementation of activities necessary to reach those targets.

2001-2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa

Who adopted this document and its mandates?

What other versions does this mandate have?

What subjects does this mandate have?

What’s in this document?

Table of contents